Sector consensus Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 04:35:35 2025-01-21 am EST			5-day change	1st Jan Change
565.80 ^DKK	+2.63%		-5.34%	-10.17%

Jan. 03	New Year, Soft Start
Jan. 03	BNP Paribas Exane Cuts Novo Nordisk PT, Maintains at Outperform	MT

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
NOVO NORDISK A/S	830.68	+50.68%	22
ELI LILLY AND COMPANY	977.47	+34.69%	26
JOHNSON & JOHNSON	171.34	+16.53%	22
ABBVIE INC.	199.93	+16.54%	27
MERCK & CO., INC.	125.55	+28.22%	24
ROCHE HOLDING AG	303.47	+13.70%	18
ASTRAZENECA PLC	172.06	+29.60%	19
NOVARTIS AG	112.38	+14.34%	19
PFIZER, INC.	31.18	+18.54%	22
AMGEN INC.	317.24	+16.58%	26
SANOFI	114.04	+15.37%	21
GILEAD SCIENCES, INC.	99.96	+8.84%	26
BRISTOL-MYERS SQUIBB COMPANY	61.01	+8.38%	21
CHUGAI PHARMACEUTICAL CO., LTD	7,430.00	+11.06%	15
GSK PLC	18.13	+33.88%	18
DAIICHI SANKYO CO., LTD.	6,344.44	+43.64%	18
HALEON PLC	3.993	+6.93%	17
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4,759.71	+18.05%	17
JIANGSU HENGRUI MEDICINE CO., LTD.	59.81	+34.34%	16
Average	1,164.86	+22.10%	21
Weighted average by Cap.	670.87	+24.79%	22